SavedAdd your journal

Journals / Türk Oftalmoloji Dergisi / 2018 / Cilt: 48 - Sayı: 4

Possible Association of Papillophlebitis with GuillainBarré Syndrome: Case Report

Merih SOYLU
Müge ÇOBAN KARATAŞ
Pages
206–208
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present this case to emphasize the importance of etiological diagnosis in papillophlebitis and the unusualpresentation of GBS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this case report, we presented a patient with visual deterioration as a result of papillophlebitis in the right eye who was later diagnosedwith Guillain-Barré syndrome (GBS).
📊
Key Findings & Data:Upon systemic and laboratory work-up to determine the etiology of papillophlebitis, the diagnosisof GBS was made and treatment was initiated immediately.
💡
Conclusion & Impact:We present this case to emphasize the importance of etiological diagnosis in papillophlebitis and the unusualpresentation of GBS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this case report, we presented a patient with visual deterioration as a result of papillophlebitis in the right eye who was later diagnosedwith Guillain-Barré syndrome (GBS). Upon systemic and laboratory work-up to determine the etiology of papillophlebitis, the diagnosisof GBS was made and treatment was initiated immediately. The ocular and systemic symptoms resolved quickly after starting intravenousimmunoglobulin therapy. We present this case to emphasize the importance of etiological diagnosis in papillophlebitis and the unusualpresentation of GBS.

🔖

Cite This Article

SOYLU, M., KARATAŞ, M. Ç. (2022). Possible Association of Papillophlebitis with GuillainBarré Syndrome: Case Report. Türk Oftalmoloji Dergisi, Cilt: 48 - Sayı: 4, 206–208. https://ajindex.com/articles/637791

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Willison HJ, Jacobs BC, van Doorn PA, Guillain-Barré syndrome. Lancet 2016;388:717-727.
  2. Nag TC, Wadhwa S. Vascular changes of the retina and choroid in systemic lupus erythematosus: pathology and pathogenesis. Curr Neurovasc Res. 2006;3:159-168.
  3. Robson MG, Walport MJ, Davies KA. Systemic lupus erythematosus and acute demyelinating polyneuropathy. Br J Rheumatol. 1994;33:1074-1077. Ropper AH. The Guillain Barre syndrome. N Engl J Med. 1992;326:1130- 1136. Jacobs BC, Rothbarth PH,van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antedecedent infections in Guillain-Barré syndrome:a case-control study. Neurology. 2010;74:581-87.
  4. Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469-482.
  5. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366:1653- 1666. Maca SM, Scharitzer M, Barisani-Asenbauer T. Uveitis and neurologic diseases: an often overlooked relationship. Wien Klin Wochenschr. 2006;118:273-279.
  6. Najman-Vainer J, Levinson RD, Graves MC, Nguyen BT, Engstrom RE Jr, Holland GN. An association between Vogt-Koyanagi-Harada disease and Guillain-Barré syndrome. Am J Ophthalmol. 2001;131:615-619.
  7. Rajska K, Rożniecki J, Loba P, Zielińska M, Broniarczyk-Loba A. Total ocular akinesis: Miller Fisher or Guillain-Barré syndrome? Neurol Neurochir Pol. 2011;45:297-300. Panosyan FB. Bilateral Ptosis due to Sympathetic Dysfunction as a Feature of Guillain-Barre Syndrome. J Clin Neuromuscul Dis. 2017;19:38-42. Méndez N, Oviedo-Pastrana M, Mattar S, Caicedo-Castro I, Arrieta G. Zika virus disease, microcephaly and Guillain-Barré syndrome in Colombia: epidemiological situation during 21 months of the Zika virus outbreak, 2015- 2017. Arch Public Health. 2017;75:65. Wang Y, Lang W, Zhang Y, Ma X, Zhou C, Zhang HL. Long-term prognosis of Guillain-Barré syndrome not determined by treatmentoptions? Oncotarget. 2017;8:79991-80001.
  8. Miller NR, Newman NJ, Biousse V, Kerrison JB. Walsh & Hoyt’s Clinical Neuro-Ophthalmology. 6th edition. Vol 1. Philadelphia PA; Lippicott Williams & Wilkins; 2004.
  9. Güngör İ, Konuk GE, Süllü Y, Arıtürk N. Papillophlebitis: Treatment of vision loss due to subretinal fluid with intravitreal ranibizumab. Neuroophthalmology. 2014;38:336-339.
  10. Fong ACO, Schatz H, McDonald HR, Burton TC, Maberley AL, Joffe L, Zegarra H, Nadel AJ, Johnson RN. Central retinal vein occlusion in young adults (pap